Pacer Advisors, Inc. Alaunos Therapeutics, Inc. Transaction History

Pacer Advisors, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$2.63 - $3.67 $33,177 - $46,297	-12,615 Closed	0 $0
Q1 2021 Apr 05, 2021	BUY	$2.82 - $5.6 $3,919 - $7,783	1,390 Added 12.38%	12,615 $45,000
Q4 2020 Jan 20, 2021	BUY	$2.09 - $3.09 $8,744 - $12,928	4,184 Added 59.42%	11,225 $28,000
Q3 2020 Oct 19, 2020	BUY	$2.39 - $3.43 $16,827 - $24,150	7,041 New	7,041 $18,000
Q4 2018 Feb 13, 2019	SELL	$1.61 - $3.62 $17,771 - $39,957	-11,038 Closed	0 $0
Q3 2018 Nov 14, 2018	BUY	$2.26 - $3.27 $24,945 - $36,094	11,038 New	11,038 $35,000
Q1 2018 May 14, 2018	SELL	$3.46 - $5.14 $10,293 - $15,291	-2,975 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$4.0 - $6.54 $11,900 - $19,456	2,975	2,975 $12,000

92.6K

Ticker TCRT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,182,000
Market Cap $422M
Description
Alaunos Therapeutics, Inc., a clinical-stage oncology-focused cell therapy company, develops adoptive TCR engineered T-cell therapies. It develops TCR Library, which is in Phase I/II clinical trial for ten TCRs reactive to mutated KRAS, TP53, and EGFR from its TCR library for the treatment of non-small cell lung, colorectal, endometrial, pancrea...

Get notified when there are updates to the investment portfolio of Pacer Advisors, Inc., based on Form 13F filings with the SEC.

Stay updated on Pacer Advisors, Inc. with notifications on news.